Autobio Diagnostics Co Ltd (603658.SS) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Supplies · China · ISIN CNE100002GC4
Autobio Diagnostics Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 4.47 bn CNY | 4.23 bn CNY |
| Gross profit | 2.89 bn CNY | 2.77 bn CNY |
| Operating income | 1.25 bn CNY | 1.15 bn CNY |
| EBIT | 1.15 bn CNY | 1.24 bn CNY |
| Net income | 1.19 bn CNY | 1.07 bn CNY |
| Diluted EPS – continuing operations | 2.07 CNY | 1.87 CNY |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Autobio Diagnostics Co Ltd
Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products in China and internationally. The company offers immunoassay, biochemistry, and microbiology products; reagents and instruments; and technical and support, and training services, as well as engages in biology research and development activities. Its immunoassay products consist of AutoLumo S900 and AutoLumo A1860 that provides user experience for small and medium size labs; AutoLumo A6200/A6600, an automatic immunoassay analyzer; AutoLumo A2000 Plus, an automated chemiluminescence immunoassay analyzer; PHOmo microplate readers; LUmo microplate luminometers; and iWO-960 microplate washers. The company's microbiology products include AutoMic-I60 for microbial identification and antibiotic susceptibility testing; AutoStreak S1800, a microbial sample pretreatment system; Autof T series and MALDI-TOF MS system for the identification of pathogenic bacteria; AutoMimo 1200, an instrument for improving pipetting efficiency and optimize workflow in the lab; BC60, an automatic blood culture instrument; and BC120, an automated bacterial culturing and detection. It also provides blood culture bottles and mycoplasma TIES reagents; AutoMolec 1600, an integrated and automated molecular diagnostics analyzer; AutoMolec 3000, an in vitro molecular detection instrument; Ci-120x and Ci-310 benchtop coagulation analyzers; and Autolas Bi 1000, Autolas Bi2600, AutoChem B861, and AutoChem B2000 automated biochemistry analyzers, as well as Autolas X series, and Autolas B series. The company was formerly known as Lifeclone Diagnostics Co., Ltd. and changed its name to Autobio Diagnostics Co., Ltd. in 2003. Autobio Diagnostics Co., Ltd. was founded in 1998 and is headquartered in Zhengzhou, China. Autobio Diagnostics Co., Ltd. is a subsidiary of Zhengzhou Autobio Co., Ltd.
More stocks
- Guangzhou Baiyun International Airport Co Ltd (600004.SS)
- CBIZ, Inc. (CBZ)
- Huaxi Securities Co Ltd Class A (002926.SZ)
- Qinhuangdao Port Co Ltd (601326.SS)
- Shenzhen hongfuhan Technology Co. Ltd. (301086.SZ)
- Netwealth Group Ltd (NWL.AX)
- Inter & Co Inc (INTR)
- Acter Co Ltd (5536.TWO)
- Shandong Weifang Rainbow Chemical Co. Ltd (301035.SZ)
- NOS SGPS SA (NOS.LS)
- Transmissora Aliança de Energia Elétrica S.A (TAEE11.SA)
- Shenzhen Gas Corp Ltd (601139.SS)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.